introduction genome-wide association study gwas identified genetic association severe acute respiratory syndrome coronavirus sars-cov-2 infection consistent complex genetic contribution infection susceptibility severity additionally epidemiological study connected outcome sars-cov-2 infection comorbidities including diabetes obesity active cancer hypertension coronary artery disease intensify sars-cov-2 health burden yet interaction genetic contribution associated complex comorbidities risk variant associated sar-cov-2 infection outcome remain unexplored reason unaware need treat sars-cov-2 infection holistically rather characterising potential causal mechanism underlying total genetic burden sars-cov-2 infection outcome comorbidities requires integrative translational approach move beyond cross-cohort genome-wide association single condition thus problem lie undertake study characterise total genetic burden sars-cov-2 infection including full suite comorbid condition gain functional understanding mechanism yet significant acute long-term sequela associated ongoing sars-cov-2 infection mean essential address interaction comorbid condition achieve step-change ability predict treat mitigate worst outcome sars-cov-2 infection covid-19 host genetics initiative covid-19 hgi http undertook meta-analysis 49,562 case million control across distinct study country identify host genetic determinant sars-cov-2 infection severity resulting disease covid-19 hgi identified variant associated severe case case moderate severe sars-cov-2 herein hospitalised severe case required respiratory support hospital died due sars-cov-2 hospitalised case hospitalised result sars-cov-2 mendelian randomisation analysis performed using priori selected phenotype identified bmi hospitalisation reported infection smoking initiation hospitalisation red blood cell count height reported infection parkinson disease hospitalisation european without ukbiobank causally related sars-cov-2 addition eight genetic trait diabetes bmi lupus ischemic stroke adhd coronary artery disease cad smoking initiation cigarette per day genetically correlated severity hospitalisation notably cad inconsistently associated infection severity despite epidemiological study confirmed strong incidence cardiovascular disease increased care setting acute infection e.g infected hospitalised intensive care biological mechanism account causal genetic relationship sars-cov-2 condition remain obscure disease biology transcriptome-wide association study analysis phenome-wide association study identified lung tissue function central understanding genetic risk contributed sars-cov-2 associated variant yet translating genetic knowledge functional understanding individual shared disease process complicated fact individual genetic variant associated complex polygenic disorder typically small effect size regulatory mechanism generally cell/tissue type-specific functional outcome intergenic trait associated genetic variant frequently associated gene non-adjacent within linear dna sequence application regulatory genomics approach emerged promising strategy identify gwas variant enriched regulatory region relevant pathophysiological basis given trait addition protein–protein interaction network pathway-based approach identified pathway gene converge disease however integration information source remains complex undertaking phenome-wide association study used screen sars-cov-2 associated risk variant association known disease trait study identified association sars-cov-2 chromosome 3p21.31 trait monocyte eosinophil neutrophil similarly sars-cov-2 associated variant rs657152 abo linked association including heart failure 1.09 1.03–1.14 0.046 diabetes 1.05 1.02–1.07 0.004 papadopoulou identified increased risk phlebitis thrombophlebitis 1.11 5.36 severe sars-cov-2 cohort increased risk leg blood clot 1.1 1.66 –16 sars-cov-2 susceptible patient finally 17q21.31 previously associated sars-cov-2 red blood cell count distribution width haemoglobin level concentration lung function trait chronic obstructive pulmonary disorder copd despite insight challenge associated interpreting genetic variant identified gwas also applies phenome-wide association study insofar functional information tissue/cell type regulatory mechanism rarely addressed combined genetic risk sars-cov-2 comorbidities predisposition systematically investigated assessed function sars-cov-2 variant lung blood brain coronary artery integrating chromatin conformation data i.e tissue-specific hi-c common genetic variation i.e minor allele frequency 0.05 designates frequency cut-off second common allele occurs given population gene expression data gtex identify spatially constrained expression quantitative trait locus i.e eqtls eqtls snp explain variation expression level mrna performed unbiased novo protein diffusion network analysis coupled tissue-specific gene regulatory network identify spatially constrained eqtls regulate encoding protein trait biological pathway link inherited risk factor sars-cov-2 recognised unrecognised phenotype result lung protein interaction network analysis identifies known unknown comorbidities sars-cov-2 infection protein interact within network likely contribute specific cellular process therefore undertook novo protein interaction network analysis explore comorbidities predisposition associated sars-cov-2 fig protein interaction network generated two stage firstly used codes3d integrate empirically defined information 3-dimensional organisation genome lung cell captured hi-c functional data lung tissue expression quantitative trait locus eqtl assign functional gene expression impact sars-cov-2 risk variant associated severe hospitalised phenotype lung tissue fig significant variant overlap hospitalised 71.3 severe 87.9 phenotype supplementary fig secondly generated protein interaction network parsing protein encoded sars-cov-2-associated spatial eqtl targeted gene string proper-seq database identify protein directly interact fig gene target identified codes3d supplementary fig formed level index set supplementary table protein interaction network protein interaction network expanded four level protein level curated interacting protein previous level fig protein expressed lung tissue gtex included expanded protein interaction network severe protein hospitalised protein supplementary table s3a replication purpose process repeated using proper-seq protein interaction dataset comparison string proper-seq restricted empirically captured protein–protein interaction figure sars-cov-2 associated gwas snp assessed ascertain locus functionality identify putative mechanism comorbid genetic predisposition trait associated sars-cov-2 codes3d pipeline generates index level set target gene supplementary fig associated severe hospitalised phenotype snp obtained covid-19 hgi supplementary table screened tissue-specific hi-c datasets identify trans trans-interchromosomal snp-gene interaction eqtl effect identified testing snp-gene pair gtex database version resulting statistically significant fdr 0.05 sars-cov-2-specific gene spatial eqtl-gene pair hospitalised severe phenotype assessed protein–protein interaction using string proper-seq database gene assessed using profiler obtain gene ontology term protein–protein interaction network analysis pipeline two part interacting protein partner level codes3d identified index level set gene level identified querying string database parameter high confidence threshold score 0.7 tissue-specific gene regulatory map queried obtain known eqtls protein within expanded network eqtls tested enrichment hypergeometric test within gwas catalog http identify associated phenotype full size image parsed known common snp maf 0.05 dbsnp154 codes3d using lung cell genome structure hi-c lung tissue gene expression data identify spatial eqtls analysis generated lung gene regulatory network grn consisted 908,356 spatial eqtls 731,067 snp maf 0.05 15,532 gene impacted gene expression within lung tissue method used lung grn obtain eqtls associated protein within level expanded protein interaction network fig eqtls gene within level expanded protein interaction network tested trait enrichment hypergeometric test within gwas catalog eqtls tested significance within level independently aggregated across level bootstrapping 1,000 randomly chosen gene set equal size severe hospitalised set supplementary fig confirmed level-specific trait non-random unique sars-cov-2 0.05 supplementary fig supplementary table expected due overlap snp hospitalised severe phenotype supplementary fig subset significant trait association shared fig unique hospitalised fig unique severe fig sars-cov-2 infection outcome supplementary table figure protein interaction network analysis identifies association sars-cov-2 complex trait protein interaction network analysis fig applied lung tissue using gene i.e severe hospitalised supplementary fig supplementary table targeted sars-cov-2 associated eqtls tissue supplementary table lung grn supplementary table trait significant following bootstrapping 0.05 shared unique hospitalised phenotype unique severe phenotype pleiotropic gene responsible trait association level shared severe phenotype shared hospitalised phenotype bi-clustering gene trait performed using constrained eqtls gene trait question bubble size proportional total number eqtls enriched trait bubble colour proportional adjusted -value bonferroni correction gwas trait enrichment full size image inspection phenotype associated eqtls protein interaction network level identifies trait obvious relevance e.g lung function support epidemiological observation e.g cardiovascular disease idiopathic pulmonary fibrosis mood disorder parkinson disease yet weakly implicated sars-cov-2 infection outcome e.g immunoglobulin vasculitis among significant 0.05 trait identified using string-informed protein interaction network replicated using network protein interaction captured within human embryonic kidney lymphocyte endothelial cell proper-seq supplementary fig supplementary table index level gene eqtls associated trait definition pleiotropic seven index level trait sars-cov-2 phenotype mood disorder fig eqtls associated index level mood disorder associated mapt kansl1 wnt3 transcript level fig b–c gene combination plekhm1 hla-dqb1 also associated gwas catalog trait parkinson disease level fig a–c trait-associated eqtls regulate mapt located across locus chromosome supplementary fig consistent existence multiple trait-specific regulatory element mapt within chromosome 17q21.31 cardiovascular disease significantly associated hospitalised adj 3.96 phenotype within lung tissue following bootstrapping fig total eqtls gene enriched cardiovascular disease lung interaction network supplementary fig supplementary table gene nos3 adk ace agt pik3cb identified druggable target supplementary table however impact therapeutic risk cardiovascular disease associated sars-cov-2 remains unknown trait affecting lung function share molecular interaction sars-cov-2 infection phenotype fig d–e however hospitalised phenotype associated lung function fev1/fvc fig supplementary table eqtls responsible hospitalised phenotype-specific lung function association linked gene supplementary fig supplementary table contrast severe sars-cov-2 phenotype associated trait typically recognised greater impact lung function e.g. chronic obstructive pulmonary disorder fig supplementary table severe lung function trait due eqtls targeting psma4 chrna3 supplementary fig f-g supplementary table chronic obstructive pulmonary disorder epidemiologically verified comorbidity severe sars-cov-2 infection tissue specific regulatory role reveal epidemiologically verified sars-cov-2 comorbidities predisposition sars-cov-2 hospitalisation death epidemiologically linked obesity diabetes neither obesity diabetes identified comorbid infection severity analysis lung fig however gene regulation tissue specific hypothesised comorbid effect associated trait mediated organ gene targeted spatially constrained eqtls identified fdr 0.05 within whole blood brain cortex using 5,594 snp associated sars-cov-2 hospitalisation severe phenotype supplementary fig supplementary table grns blood brain cortex 1,050,155 spatial eqtls involving 862,964 snp 14,428 gene supplementary table generated trait associated fdr 0.05 sars-cov-2 protein interaction network within blood brain tissue respectively following bootstrapping fig supplementary fig supplementary table type diabetes autoimmune thyroid disease adj 3.87 type diabetes age diagnosis adj 1.76 –11 significantly associated sars-cov-2 severe hospitalisation phenotype whole blood tissue fig association replicated analysis protein interaction derived proper-seq supplementary fig supplementary table eqtls pleiotropic gene located within hla region chromosome associated type diabetes age diagnosis across phenotype blood supplementary table supplementary fig concordant major genetic susceptibility determinant type diabetes figure additional trait associated sars-cov-2 infection severity blood brain protein interaction network analysis fig applied whole blood brain tissue using gene i.e severe hospitalised blood severe hospitalised brain supplementary fig supplementary table targeted sars-cov-2 associated eqtls tissue supplementary table blood brain grns supplementary table blood tissue trait identified string protein interaction shared across severe hospitalised phenotype shared observed brain trait significant following bootstrapping 0.05 shown bubble size proportional total number eqtls enriched trait bubble colour proportional adjusted -value bonferroni correction gwas trait enrichment heatmaps highlight gene associated level trait severe hospitalised phenotype brain full size image compared multimorbid trait significantly associated following bootstrapping sars-cov-2 infection severity across lung blood brain grns supplementary fig identified eqtls regulating gene enriched trait e.g parkinson disease shared across tissue fdr 0.05 supplementary fig supplementary table however whilst trait shared distinct tissue-specific eqtl gene profile responsible enrichment trait supplementary fig notably among unique trait blood trait associated hospitalised phenotype e.g cholesterol fatty acid measure serum metabolite chronic kidney disease enriched eqtls targeting fads2-fads1 gene supplementary fig identification shared risk cardiovascular disease factor sars-cov-2 infection cardiovascular disease known risk factor acute post-acute sars-cov-2 aetiology coronary artery disease cad associated sars-cov-2 phenotype blood prior bootstrapping adj 3.20 4.08 hospitalised severe respectively supplementary table similarly cad associated severe phenotype adj 0.004 supplementary table coronary artery prior bootstrapping following supplementary fig indicating association tissue may unique sars-cov-2 however still statistically biologically relevant based epidemiological study cad remained associated hospitalised phenotype brain following bootstrap adj 0.03 fig supplementary table cad-association brain fig supplementary table due spatially constrained eqtls gene formed protein cluster protein within expanded protein interaction network supplementary fig supplementary table gene e.g erbb4 notch4 hsd17b12 pathway e.g erbb signaling pathway 9.36 fatty acid metabolism 2.16 recognised relevance cad sars-cov-2 notably one eqtl identified regulating erbb4 within brain regulatory map mapped erbb4 gwas supplementary table trait known increase risk cardiovascular event i.e takayasu arteritis hospitalised adj 9.51 severe adj 0.001 giant cell arteritis hospitalised adj 7.66 severe adj 4.89 immunoglobulin vasculitis hospitalised adj severe adj 1.89 –76 clotting factor i.e fibrinogen level hospitalised adj 6.30 severe adj 0.009 associated phenotype blood fig supplementary table brain i.e immunoglobulin vasculitis hospitalised adj 4.41 severe adj 2.23 fig severe lung i.e immunoglobulin vasculitis adj 0.007 fibrinogen level adj 0.03 fig discussion study integrated protein interaction network tissue-specific gene regulatory network identify comorbidities predisposition sars-cov-2 infection outcome mechanism potentially link without priori assumption analysis identified known comorbid trait cad type diabetes mood disorder asthma etc evidence genetic predisposition trait previously associated weakly associated sars-cov-2 also obtained i.e. parkinson disease alzheimer disease hirschsprung disease inflammatory bowel disease collectively result support potential much greater post-acute sars-cov-2 burden genetic predisposition realised pathway network-based approach used anchor convergence disease shared genetic aetiology two key implication new understanding genetic biophysical interaction complex condition sars-cov-2 infection firstly therapeutic stratification acute post-acute sars-cov-2 patient according genetically defined comorbidities possible analysing individualised combined genetic burden sars-cov-2 infection outcome comorbidities secondly therapeutic address comorbidities thus potentially reduce impact interaction sars-cov-2 infection may clinically viable applied individual predisposing genetic burden discovery-based protein interaction network approach developed uncovered putative mechanism comorbid genetic predisposition trait associated sars-cov-2 however study several limitation study cohort within gwas catalogue biased participant european descent identification trait limited listed gwas catalog 02-12-2021 example covid-19 hgi variant listed gwas catalog analysis performed limited analysis common genetic variant maf 0.05 inclusion rare variant larger effect size may possibly impact additional pathway greater phenotypic consequence include epigenetic data capture environmental interaction within analysis instance considered downstream effect change transcription factor target information transcript level gene expression protein interaction network dependent upon curated protein interaction data string proper-seq likely datasets capture biologically relevant protein interaction finally obtain protein interaction spatial genome hi-c gene expression data identical sample therefore inter-sample variation different datasets impact analysis population control used covid-19 hgi consortium individual without knowledge sars-cov-2 infection covid-19 status although definition population control may lead biased effect size estimate individual exposed virus became infected sars-cov-2 developed severe covid-19 covid-19 host genetics initiative consortium acknowledge limitation however covid-19 host genetics initiative conducted sensitivity analysis determined use population control infectious disease host genetic study valid approach several target gene identified within index level novel due incorporation variant suggestive significance spatial regulatory information example smarca4 identified targeted lung specific eqtls rs10416073 rs7247198 severe phenotype within limitation covid-19 host genetics initiative definition notably gene identified target sars-cov-2 gwas however smarca4 identified crispr screen second strongest sars-cov-2 pro-viral gene ace2 contend convergence result candidate gene population study support putative biological importance expanded finding compared sars-cov-2 gwas study identified tissue-specific pleiotropy sars-cov-2 infection genetic risk parkinson disease neurological condition mood disorder parkinson disease identified causally related sars-cov-2 whilst biological relevance relationship unclear identified total variant gene e.g mapt crhr1 kansl1 across tissue tested associated link association driven predominantly hla region i.e 6p21 variant 17q21.31 locus consistent finding 17q21.31 locus identified linking sars-cov-2 parkinson disease likely driven recognised inversion region expanded proposed 17q21.31 linkage sars-cov-2 parkinson disease identifying variant pleiotropic gene i.e tlk1 fdft1 blood located outside 17q21.31 6p21 also associated trait moreover integration spatial constraint identification tissue-specific regulatory connection i.e constrained eqtls reduced overall number trait gene associated pleiotropic 17q21.31 locus whilst long-term significance sars-cov-2 infection parkinson disease onset severity remains inadequately understood area concern notably spanish flu influenza h1n1 virus pandemic resulted increase incidence parkinson disease therefore contend genetic architecture protein interaction identified may represent high-value therapeutic target affect causal relationship reduce long-term increase incidence parkinson disease following sars-cov-2 infection consistent epidemiological observation identified type diabetes age diagnosis associated severe hospitalised phenotype defined covid-19 host genetics initiative association due pleiotropic gene e.g notch4 collectively result suggest several putative mechanism may link type diabetes sars-cov-2 infection cardiovascular disease burden increase according severity sars-cov-2 infection however mechanism increase occurs unknown hospitalised phenotype identified gene eqtls enriched cardiovascular disease lung protein interaction network gene eqtls enriched cad-association brain protein interaction network reproduced expanded known genetic correlation cad sars-cov-2 including tissue specific spatial regulatory mechanism analysis protein encoded cad-associated gene brain e.g erbb4 eqtl rs582384 functioned within pathway e.g. erbb signaling pathway activated cad exerting disease mitigation regenerative effect preventing pathological process i.e atherosclerosis trigger cad therefore since variant identified found germline contend genetic predisposition cad amplify risk adverse sars-cov-2 outcome moreover individual develop cad following sars-cov-2 infection infection activates existing albeit unrecognised genetic predisposition cad erbb4 found interacting significantly ngr1 ngr-1 agonist erbb4 receptor nrg-1/erbb4 signalling system critical mitigation heart failure outcome late-stage cad circulating nrg-1 level inversely related severity cad lesion reduces magnitude ischemic heart brain injury inhibits atherogenesis via suppression macrophage cell formation nrg-1 also inhibits cellular senescence key contributor atherosclerosis via erbb4 clinical trial recombinant nrg-1 acting via erbb4 successfully improved overall survival cohort 1,600 patient heart failure conclusion network approach developed anchor known sars-cov-2 comorbidities previously undescribed genetic predisposition shared genetic aetiology identifies molecular insight potential therapeutic target collectively finding pave way patient stratification simply based visible comorbidities depth understanding genetic impact trait collectively alter individual predisposition acute post-acute sars-cov-2 infection outcome method genetic variant used study genome-wide association study gwas data sars-cov-2 clinical phenotype obtained covid-19 host genetics initiative covid-19 hgi single nucleotide polymorphism snp hospitalised versus population severe hospitalised death respiratory support versus population -value threshold cohort obtained covid-19 hgi release http supplementary table full summary statistic detail covid-19 hgi available http assigning putative transcriptional function sars-cov-2 snp severe hospitalised sars-cov-2 associated snp analysed separately using codes3d identify phenotype-specific spatially constrained expression quantitative trait locus eqtls target gene supplementary table phenotype-specific i.e hospitalised severe spatial connection snp-gene pair identified hi-c chromatin contact data derived human lung primary tissue blood peripheral blood cell peripheral blood cd4 cell peripheral blood cd8 cell peripheral blood cell brain dorsolateral prefrontal cortex cell coronary artery smooth muscle cell identify snp eqtls snp-gene pair used query lung whole blood brain cortex coronary artery within gtex database multiple testing corrected using benjamini–hochberg procedure fdr 0.05 interaction kept logarithm allelic fold change log_afc 0.05 eqtl gene chromosome position annotated according human reference genome grch38/hg19 analysis analysis conducted eqtl-gene combination using ldlink 4.0 ldmatrix tool http tab=ldmatrix parameter included snp rsid number dbsnp154 genotyping data phase version genome project european population generation gene regulatory network generated gene regulatory network grns included spatially constrained eqtls known snp maf 0.05 dbsnp154 lung whole blood dbgap accession phs000424.v8.p2 approved project number brain cortex gtex 8.0 snp screened codes3d one chromosome time multiple testing corrected using benjamini–hochberg procedure fdr 0.05 interaction kept logarithm allelic fold change log_afc 0.05 protein–protein interaction network analysis curated protein–protein interaction data obtained string http string mined using list gene targeted spatially constrained eqtls following parameter experiment text mining co-expression database specie limited homo sapiens interaction score 0.7 experimentally validated protein interaction data also obtained protein–protein interaction sequencing proper-seq tool database v1.0 http protein interaction obtained hek293t cell jurkat cell human umbilical vein endothelial cell huvecs gene targeted spatially constrained eqtls imputed proper-seq tool discover additional cell-line specific protein–protein interaction expanded protein–protein interaction network analysis expanded protein–protein interaction network analysis first take gene interest i.e sars-cov-2 gene identified codes3d par gene string proper-seq database identify protein interaction fig input gene list assigned level protein level include protein curated interaction previous level protein within level may may interact gene encode protein present within level protein interaction network 0–4 mined lung whole blood brain-specific grns identify significant adj 0.05 spatially constrained regulatory eqtls associated gene interest fig spatially constrained eqtls tested enrichment within snp associated gwas trait within gwas catalogue curated gwas association downloaded nhgri-ebi gwas catalogue 02-12-2021 statistically significant eqtl enrichment determined hypergeometric distribution analysis 0.05 calculated total number spatially constrained eqtls protein interaction network level bonferroni correction multiple hypothesis testing calculated enriched eqtls using -value list number test performed eqtls adjusted -value 0.05 selected significant bootstrapping analysis 1,000 iteration conducted determine trait identified protein interaction network level uniquely associated sars-cov-2 gene list size protein interaction network input datasets i.e severe hospitalised lung severe hospitalised blood severe hospitalised brain severe hospitalised coronary artery supplementary fig supplementary table generated randomly genbank protein interaction network analysis pipeline run lung blood brain coronary artery tissue using random gene list number shared trait compiled python dictionary calculated significance according frequency trait/1000 trait -value 0.05 deemed unique sars-cov-2 functional pathway enrichment analysis gene ontology kyoto encyclopedia gene genome kegg pathway enrichment analysis conducted using profiler http reactome reac wikipathways transfac mirtarbase mirna human protein atlas hpa corum human phenotype ontology database pathway significant term selected threshold adjusted -value 0.05 data visualisation used study studio version 1.3.959 ggplot2 venndiagram upsetr package used visualise result cytoscape version 3.8.2 used visualising string network k-means clustering performed using package pheatmap